Validated Platform Inventia's RASTRUM Validated Solutions offer decision-grade data from human-relevant three-dimensional cell models, enabling faster go/no-go decisions in drug discovery. This positions the company to target pharma and biotech R&D labs seeking reproducible workflows that integrate with existing systems. Opportunities include selling validation services, implementation support, and long-term licensing alongside core platform access.

Global Partnerships With strategic expansion into the US and India supported by distributors and partnerships, there is a clear channel model to reach high-value markets. Sales teams should prioritize onboarding regional partners, providing localized training, and co-marketing to accelerate adoption in local pharma and CRO ecosystems.

Ecosystem Play Collaborations with Xylyx Bio for bioinks and distribution deals with regional partners show a strategy of building an ecosystem around advanced cell models. This creates cross-sell opportunities for bioinks, model kits, and joint workflows that appeal to research customers requiring end-to-end solutions.

Enterprise Growth Evidence of investor funding and government support signals capacity to scale deployments across larger enterprises and multi-site programs. Focus on enterprise customers such as global pharma and large CROs with multi-site installations and sustained service contracts, rather than point solutions.

Data Driven Value Strength of reproducibility and workflow integration, plus cloud-enabled tech stack, suggests strong appeal to labs prioritizing data integrity and scalable analysis. Sales storytelling can highlight compatibility with customers' data ecosystems, potential for cloud-based collaboration, and analytics-driven decision making.